AR128560A1 - Cápsula blanda de ácido valproico de liberación modificada - Google Patents

Cápsula blanda de ácido valproico de liberación modificada

Info

Publication number
AR128560A1
AR128560A1 ARP230100387A ARP230100387A AR128560A1 AR 128560 A1 AR128560 A1 AR 128560A1 AR P230100387 A ARP230100387 A AR P230100387A AR P230100387 A ARP230100387 A AR P230100387A AR 128560 A1 AR128560 A1 AR 128560A1
Authority
AR
Argentina
Prior art keywords
soft capsule
weight
shell composition
valproic acid
composition comprises
Prior art date
Application number
ARP230100387A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR128560A1 publication Critical patent/AR128560A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP230100387A 2022-02-18 2023-02-17 Cápsula blanda de ácido valproico de liberación modificada AR128560A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263311559P 2022-02-18 2022-02-18

Publications (1)

Publication Number Publication Date
AR128560A1 true AR128560A1 (es) 2024-05-22

Family

ID=87579078

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100387A AR128560A1 (es) 2022-02-18 2023-02-17 Cápsula blanda de ácido valproico de liberación modificada

Country Status (12)

Country Link
US (1) US20250177312A1 (cg-RX-API-DMAC10.html)
EP (1) EP4479033A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025506678A (cg-RX-API-DMAC10.html)
KR (1) KR20240145031A (cg-RX-API-DMAC10.html)
CN (1) CN118647373A (cg-RX-API-DMAC10.html)
AR (1) AR128560A1 (cg-RX-API-DMAC10.html)
AU (1) AU2023221972A1 (cg-RX-API-DMAC10.html)
CA (1) CA3244352A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024012216A2 (cg-RX-API-DMAC10.html)
IL (1) IL314788A (cg-RX-API-DMAC10.html)
MX (1) MX2024010123A (cg-RX-API-DMAC10.html)
WO (1) WO2023158777A1 (cg-RX-API-DMAC10.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CA2853965A1 (en) * 2011-11-03 2013-05-10 Gtx, Inc. Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20170312226A1 (en) * 2016-04-28 2017-11-02 Ascent Pharmaceuticals, Inc. Pharmaceutical dosage forms
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment
CA3185807A1 (en) * 2020-06-02 2021-12-02 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
IL314788A (en) 2024-10-01
CA3244352A1 (en) 2023-08-24
KR20240145031A (ko) 2024-10-04
WO2023158777A1 (en) 2023-08-24
MX2024010123A (es) 2024-08-27
CO2024012216A2 (es) 2024-09-30
US20250177312A1 (en) 2025-06-05
CN118647373A (zh) 2024-09-13
EP4479033A1 (en) 2024-12-25
AU2023221972A1 (en) 2024-09-19
EP4479033A4 (en) 2026-03-04
JP2025506678A (ja) 2025-03-13

Similar Documents

Publication Publication Date Title
AR124044A1 (es) Cápsulas blandas de liberación retardada
ES2603225T3 (es) Sistema de cápsulas blandas sin gelatina
US9895672B2 (en) High strength seamless alginate capsules
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
CA2633924A1 (en) Gastric reflux resistant dosage forms
KR880701544A (ko) 이온화 가능한 의약 제제용 용해 시스템
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
JP2009521269A5 (cg-RX-API-DMAC10.html)
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
IL276943B1 (en) Enteric softgel capsules
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
RU2020101477A (ru) Фармацевтические композиции, содержащие дглк, и их применение
RU2019115816A (ru) Фармацевтическая композиция
RU2010120706A (ru) Композиция липоевой кислоты в виде шариков
AR122512A1 (es) Cápsulas blandas de liberación retardada
CO2021015117A2 (es) Composición de naproxeno en cápsula blanda miniatura
MX2021010959A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas.
CN101584889A (zh) 一种用于治疗牙周病的外用原位成型基质
BR112022021906A2 (pt) Sistema e método de encapsulamento de ferramenta rotativa de duas partes para fabricação de cápsulas
CN100512804C (zh) 一种植物性肠溶空心硬胶囊的制作方法
AU2024373379A1 (en) Formulations for di- or tri-halogenated methane generation and uses thereof
CO2024012216A2 (es) Cápsula blanda de ácido valproico de liberación modificada
Saavedra et al. Antagonistic effects of tryptamine and β-phenylethylamine on the behaviour of rodents
JP2025506678A5 (cg-RX-API-DMAC10.html)
RU2024126869A (ru) Содержащая вальпроевую кислоту капсула модифицированного высвобождения из мягкого желатина